HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo (Q41071784)

26 September 2017

HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo (English)

1 reference

26 September 2017

0 references

Goh WC

1

1 reference

26 September 2017

Rogel ME

2

1 reference

26 September 2017

Kinsey CM

3

1 reference

26 September 2017

Michael SF

4

1 reference

26 September 2017

Fultz PN

5

1 reference

26 September 2017

Nowak MA

6

1 reference

26 September 2017

Hahn BH

7

1 reference

26 September 2017

Emerman M

8

1 reference

26 September 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

26 September 2017

1 reference

26 September 2017

4

1 reference

26 September 2017

1

1 reference

26 September 2017

65-71

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0198-065

26 September 2017

0 references

cites work

DNA tumor virus transforming proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

HIV-1, Vpr and the cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Gene acquisition in HIV and SIV

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology.

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Vpr-induced cell cycle arrest is conserved among primate lentiviruses.

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Distinct roles for cyclin-dependent kinases in cell cycle control

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Viral variability and serum antibody response in a laboratory worker infected with HIV type 1 (HTLV type IIIB).

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Nonsense mutations in the vpr gene of HIV-1 during in vitro virus passage and in HIV-1 carrier-derived peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Cell cycle regulation of the human polo-like kinase (PLK) promoter.

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0198-065

7 January 2021

Identifiers

DOI

10.1038/NM0198-065

1 reference

Dimensions Publication ID

26 September 2017

0 references

1 reference